Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-01-11, Stock:ABBV, The news for the past five days is as follows:
2021-01-04: NEWS1: Drugmakers kick off 2021 with 500 U.S. price hikes.
2021-01-05: NEWS1: AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know.NEWS2: AbbVie Is a Stock to Position for 2021.NEWS3: Risankizumab (SKYRIZI®) Phase 3 Results Demonstrate Improvements in Disease Activity Across Joint and Skin Symptoms Among Psoriatic Arthritis Patients.NEWS4: Got $1,000? These 2 Top Stocks Can Make You Rich.
2021-01-06: NEWS1: Correctional Service Canada COVID-19 Vaccine Roll-out.NEWS2: Why AbbVie (ABBV) Could Beat Earnings Estimates Again.NEWS3: 4 High-Yield Stocks to Ring in the New Year.NEWS4: AbbVie's (ABBV) Skyrizi Succeeds in Psoriatic Arthritis Studies.NEWS5: AbbVie to Present at the 39th Annual J.P. Morgan Healthcare Conference.
2021-01-07: NEWS1: AbbVie Is Mizuho’s Top Pick Among Large-Cap Biopharma Stocks.NEWS2: Risankizumab (SKYRIZI®) Demonstrates Significant Improvements in Clinical Remission and Endoscopic Response in Two Phase 3 Induction Studies in Patients with Crohn's Disease.NEWS3: 3 Biotech Technological Developments to Watch Out For in 2021.
2021-01-08: NEWS1: 3 Low Forward Price-Earnings Ratio Stock Picks.NEWS2: Pharma Stock Roundup: ABBV's Positive Skyrizi Data, AZN, PFE, RHHBY's FDA Updates.NEWS3: AbbVie's (ABBV) Skyrizi Succeeds in Crohn's Disease Studies.

Answer: Rise